Iron release, oxidative stress and erythrocyte ageing

Free Radical Biology and Medicine

Volumn 32, Issue 7, 2002, Pages 568-576

  Comporti, Mario ^a   Signorini, Cinzia ^a   Buonocore, Giuseppe ^a   Ciccoli, Lucia ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

Erythrocytes; Free radicals; Iron release; Oxidative stress; Plasma nonprotein bound iron; Senescent cell antigen

Indexed keywords

CELL ANTIGEN; DEFEROXAMINE; DIVICINE; DNA; FERRITIN; FERROZINE; GLUTATHIONE; HEMOGLOBIN; HEMOGLOBIN A; HEMOGLOBIN F; HEMOPROTEIN; HYDRAZONE DERIVATIVE; IMMUNOGLOBULIN G; IRON; MEMBRANE PROTEIN; PHENYLHYDRAZINE; QUERCETIN; TRANSFERRIN;

BETA THALASSEMIA; DRUG INTOXICATION; DRUG MECHANISM; ERYTHROCYTE LIFESPAN; ERYTHROCYTE MEMBRANE; HEMOLYSIS; HUMAN; IRON CHELATION; IRON KINETICS; IRON TRANSPORT; ISCHEMIA; LIPID PEROXIDATION; LIVER; MEMBRANE BINDING; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; REPERFUSION; REVIEW;

EID: 0036532552     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(02)00759-1     Document Type: Article

References (61)

1. The toxicology of molecular oxygen
2. Oxygen toxicity, oxygen radicals, transition metals and disease
3. Iron transport and storage
4. The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells
5. Ferritin and superoxide dependent lipid peroxidation
6. Rat liver microsomal NADPH-dependent release of iron from ferritin and lipid peroxidation
7. Release of iron from ferritin by divicine, isouramil, acid-hydrolyzed vicine and dialuric acid and initiation of lipid peroxidation
8. Sources and role of iron in lipid peroxidation
9. Ferritin as a source of iron for oxidative damage
10. Iron promoters of the Fenton reaction and lipid peroxidation can be released from haemoglobin by peroxides
11. Formation of hydroxyl radicals from hydrogen peroxide in the presence of iron
12. Senescent cell antigen is immunologically related to band 3
13. Localization of senescent cell antigen on band 3
14. The role of hemoglobin denaturation and band 3 clustering in red blood cell aging
15. Poly-N-acetyllactosaminyl saccharide chains of band 3 as determinants for anti-band 3 autoantibody binding to senescent and oxidized erythrocytes
16. Naturally occurring anti-band-3 antibodies and complement together mediate phagocytosis of oxidatively stressed human erythrocytes
17. Binding of anti-band 3 autoantibody to oxidatively damage erythrocytes
18. Oxidation as a possible mechanism of cellular aging: Vitamin E deficiency causes premature aging and IgG binding to erythrocytes
19. Life span of the fetal red blood cell
20. Studies on erythro-kinetics in infancy. 13. The mean life span and the life span frequency function of red blood cells formed during foetal life
21. Iron release and membrane damage in erythrocytes exposed to oxidizing agents, phenylhydrazine, divicine and isouramil
22. Allyl alcohol-induced hemolysis and its relation to iron release and lipid peroxidation
23. Iron release and erythrocytes damage in allyl alcohol intoxication in mice
24. Evidence that desferrioxamine cannot enter cells by passive diffusion
25. Chelating and free radical scavenging mechanisms of inhibitory action of rutin and quercetin in lipid peroxidation
26. Protective effect of quercetin and rutin on photosensitized lysis of human erythrocytes in the presence of hematoporphyrin
27. Inhibition of phthalocyanine-sensitized photohemolysis of human erythrocytes by quercetin
28. Protection against oxidative damage of erythrocyte membrane by the flavonoid quercetin and its relation to iron chelating activity
29. Iron release, membrane protein oxidation and erythrocyte ageing
30. Studies of factors regulating the ageing of human erythrocytes - III. Metabolism and fate of erythrocytic vesicles
31. Protection of erythrocytes against oxidative damage and autologous immunoglobulin G (IgG) binding by iron chelator fluor-benzoil-pyridoxal hydrazone
32. The molecular pathobiology of cell membrane iron: The sickle red cell as a model
33. Clustering of integral membrane proteins of the human erythrocyte membrane stimulates autologous IgG binding, complement deposition, and phagocytosis
34. Iron release in erythrocytes from patients with β-thalassemia
35. Iron released from an erythrocyte lysate by oxidative stress is diffusible and in redox active form
36. Release of free, redox-active iron in the liver and DNA oxidative damage following phenylhydrazine intoxication
37. Synthesis of hemoglobin in a cell-free system. I. Properties of the complete system
38. DNA damage by oxygen-derived species - Its mechanisms and measurement in mammalian systems
39. Hemolytic drugs aniline and dapsone induce iron release in erythrocytes and increase the free iron pool in spleen and liver
40. Metals, oxidative stress, and hepatic fibrogenesis
41. Iron mobilization from crocidolite as enhancer of collagen content in rat lung fibroblasts
42. Cross-linking of red blood cell membrane proteins induced by oxidative stress in β-thalassemia
43. Oxidant damage of lipids and proteins of the erythrocyte membranes in unstable hemoglobin disease: Evidence for the role of lipid peroxidation
44. Effect of excess α-hemoglobin chains on cellular and membrane oxidation in model β-thalassemic erythrocytes
45. Formation of superoxide in the autoxidation of the isolated α and β chains of human hemoglobin and its involvement in hemichrome precipitation
46. Nonrandom association of free iron with membranes of sickle and β-thalassemic erythrocytes
47. Hypoxia-induced free iron release in the red cells of newborn infants
48. Iron release in newborn and adult erythrocytes exposed to hypoxia-reoxygenation
49. Nucleated red blood cell count at birth as an index of perinatal brain damage
50. Bleomycin-detectable iron in the plasma of premature and fullterm neonates
51. Ferrous ions detected in iron-overloaded cord blood plasma from preterm and term babies: Implications for oxidative stress
52. Nonprotein-bound iron in postasphyxial reperfusion injury of the newborn
53. Nontransferrin-bound iron in plasma from hemochromatosis patients: Effect of phlebotomy therapy
54. The assessment of serum nontransferrin-bound iron in chelation therapy and iron supplementation
55. Nonspecific serum iron in thalassaemia: An abnormal serum iron fraction of potential toxicity
56. Kinetics of removal and reappearance of non-transferrin-bound plasma iron with deferoxamine therapy
57. Intraerythrocyte nonprotein-bound iron and plasma malondialdheyde in the hypoxic newborn
58. Total hydroperoxide and advanced oxidation protein products in preterm hypoxic babies
59. Biomarkers of oxydative stress in preterm newborns
60. Plasma nonprotein bound iron in newborn infants at birth: A reliable new index of fetal redox stress
61. The structure of horse methaemoglobin at 2.0 Å